PDS Biotechnology Corp Stock-Based Compensation
PDS Biotechnology Corp (PDSB) reported Stock-Based Compensation of $2.28 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-13
- PDS Biotechnology Corp share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $1.13M, a 151.34% increase year-over-year.
- PDS Biotechnology Corp share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.16M, a 7.77% decline year-over-year.
- PDS Biotechnology Corp share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.16M, a 29.56% decline year-over-year.
- PDS Biotechnology Corp share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.25M, a 29.90% decline year-over-year.
- PDS Biotechnology Corp share-based payment arrangement, noncash expense for fiscal 2025 was $4.11M, a 40.03% decline from fiscal 2024.
- PDS Biotechnology Corp share-based payment arrangement, noncash expense for fiscal 2024 was $6.85M, a 10.06% decline from fiscal 2023.
- PDS Biotechnology Corp share-based payment arrangement, noncash expense for fiscal 2023 was $7.61M, a 46.54% increase from fiscal 2022.
- PDS Biotechnology Corp share-based payment arrangement, noncash expense for fiscal 2022 was $5.20M, a 27.53% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.28M 10-Q · filed 2026-08-13 | $3.44M derived: sum of 3 quarters · filed 2026-08-13 | $4.69M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $1.16M 10-Q · filed 2026-05-14 | $2.31M derived: sum of 2 quarters · filed 2026-05-14 | $3.56M derived: sum of 3 quarters · filed 2026-05-14 | $4.01M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $2.40M derived: sum of 2 quarters · filed 2026-03-30 | $2.85M derived: sum of 3 quarters · filed 2026-08-13 | $4.11M 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.69M derived: sum of 2 quarters · filed 2026-08-13 | $2.95M 10-Q · filed 2025-11-13 | $4.59M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $448.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $1.70M 10-Q · filed 2026-08-13 | $3.35M derived: sum of 3 quarters · filed 2026-08-13 | $5.12M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $1.25M 10-Q · filed 2026-05-14 | $2.90M derived: sum of 2 quarters · filed 2026-05-14 | $4.68M derived: sum of 3 quarters · filed 2026-05-14 | $6.47M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $3.42M derived: sum of 2 quarters · filed 2026-03-30 | $5.22M derived: sum of 3 quarters · filed 2026-03-30 | $6.85M 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.57M derived: sum of 2 quarters · filed 2025-11-13 | $5.20M 10-Q · filed 2025-11-13 | $6.56M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $3.43M 10-Q · filed 2025-08-13 | $4.78M derived: sum of 3 quarters · filed 2025-08-13 | $6.85M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $1.63M 10-Q · filed 2025-05-14 | $2.98M derived: sum of 2 quarters · filed 2025-05-14 | $5.06M derived: sum of 3 quarters · filed 2025-05-14 | $7.16M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $3.43M derived: sum of 2 quarters · filed 2025-03-27 | $5.53M derived: sum of 3 quarters · filed 2025-03-27 | $7.61M 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $2.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $4.18M derived: sum of 2 quarters · filed 2024-11-14 | $6.26M 10-Q · filed 2024-11-14 | $7.63M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $4.19M 10-Q · filed 2024-08-13 | $5.56M derived: sum of 3 quarters · filed 2024-08-13 | $6.90M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $2.08M 10-Q · filed 2024-05-15 | $3.45M derived: sum of 2 quarters · filed 2024-05-15 | $4.80M derived: sum of 3 quarters · filed 2024-05-15 | $6.15M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $2.72M derived: sum of 2 quarters · filed 2024-03-28 | $4.07M derived: sum of 3 quarters · filed 2024-03-28 | $5.20M 10-K · filed 2024-03-28 | ||||
| 2022-09-30 | $1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $2.69M derived: sum of 2 quarters · filed 2023-11-14 | $3.82M 10-Q · filed 2023-11-14 | $5.50M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $1.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.48M 10-Q · filed 2023-08-14 | $4.15M derived: sum of 3 quarters · filed 2023-08-14 | $5.85M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $1.13M 10-Q · filed 2023-05-15 | $2.80M derived: sum of 2 quarters · filed 2023-05-15 | $4.50M derived: sum of 3 quarters · filed 2023-05-15 | $4.95M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $3.38M derived: sum of 2 quarters · filed 2023-03-28 | $3.82M derived: sum of 3 quarters · filed 2023-03-28 | $4.07M 10-K · filed 2023-03-28 | ||||
| 2021-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.14M derived: sum of 2 quarters · filed 2022-11-14 | $2.40M 10-Q · filed 2022-11-14 | $2.53M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $441.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $699.22K 10-Q · filed 2022-08-08 | $830.64K derived: sum of 3 quarters · filed 2022-08-08 | $960.43K derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | $257.62K 10-Q · filed 2022-05-11 | $389.05K derived: sum of 2 quarters · filed 2022-05-11 | $518.84K derived: sum of 3 quarters · filed 2022-05-11 | $564.95K derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | $131.42K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $261.21K derived: sum of 2 quarters · filed 2022-03-31 | $307.33K derived: sum of 3 quarters · filed 2022-03-31 | $432.32K 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $129.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $175.91K derived: sum of 2 quarters · filed 2021-11-10 | $300.90K 10-Q · filed 2021-11-10 | $546.29K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $46.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $171.11K 10-Q · filed 2021-08-12 | $416.50K derived: sum of 3 quarters · filed 2021-08-12 | $536.71K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $124.99K 10-Q · filed 2021-05-13 | $370.39K derived: sum of 2 quarters · filed 2021-05-13 | $490.59K derived: sum of 3 quarters · filed 2021-05-13 | $509.17K derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $245.40K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $365.60K derived: sum of 2 quarters · filed 2021-03-18 | $384.18K derived: sum of 3 quarters · filed 2021-03-18 | $3.14M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $120.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $138.79K derived: sum of 2 quarters · filed 2020-11-13 | $2.89M 10-Q · filed 2020-11-13 | $3.71M derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $18.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $2.77M 10-Q · filed 2020-08-13 | $3.59M derived: sum of 3 quarters · filed 2020-08-13 | $3.59M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $2.75M 10-Q · filed 2020-05-13 | $3.57M derived: sum of 2 quarters · filed 2020-05-13 | $3.57M derived: sum of 3 quarters · filed 2020-05-13 | $3.61M derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | $817.51K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $815.20K derived: sum of 2 quarters · filed 2020-03-27 | $859.83K derived: sum of 3 quarters · filed 2020-03-27 | $866.85K 10-K · filed 2020-03-27 | $7.47M 10-K · filed 2019-02-21 | |||
| 2018-09-30 | -$2.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $42.32K derived: sum of 2 quarters · filed 2019-11-07 | $49.34K 10-Q · filed 2019-11-07 | $5.55M 10-Q · filed 2018-11-01 | $1.60M derived: sum of 4 quarters · filed 2019-11-07 | |||
| 2018-06-30 | $44.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $51.64K 10-Q · filed 2019-08-01 | $3.64M 10-Q · filed 2018-08-01 | $1.60M derived: sum of 3 quarters · filed 2019-08-01 | $3.17M derived: sum of 4 quarters · filed 2019-08-01 | |||
| 2018-03-31 | $7.01K 10-Q · filed 2019-05-14 | $1.99M 10-Q · filed 2018-05-01 | $1.55M derived: sum of 2 quarters · filed 2019-05-14 | $3.12M derived: sum of 3 quarters · filed 2019-05-14 | $4.70M derived: sum of 4 quarters · filed 2019-05-14 | |||
| 2017-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $3.12M derived: sum of 2 quarters · filed 2019-02-21 | $4.70M derived: sum of 3 quarters · filed 2019-02-21 | $6.18M 10-K · filed 2019-02-21 | ||||
| 2017-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $3.15M derived: sum of 2 quarters · filed 2018-11-01 | $4.64M 10-Q · filed 2018-11-01 | $5.91M derived: sum of 4 quarters · filed 2018-11-01 | ||||
| 2017-06-30 | $1.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $3.07M 10-Q · filed 2018-08-01 | $4.34M derived: sum of 3 quarters · filed 2018-08-01 | $5.58M derived: sum of 4 quarters · filed 2018-08-01 | ||||
| 2017-03-31 | $1.49M 10-Q · filed 2018-05-01 | $2.76M derived: sum of 2 quarters · filed 2018-05-01 | $3.99M derived: sum of 3 quarters · filed 2018-05-01 | $5.38M derived: sum of 4 quarters · filed 2018-05-01 | ||||
| 2016-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $2.51M derived: sum of 2 quarters · filed 2018-03-01 | $3.89M derived: sum of 3 quarters · filed 2018-03-01 | $5.31M 10-K · filed 2018-03-01 | ||||
| 2016-09-30 | $1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $2.61M derived: sum of 2 quarters · filed 2017-11-01 | $4.03M 10-Q · filed 2017-11-01 | $5.36M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $2.80M 10-Q · filed 2017-08-01 | $4.13M derived: sum of 3 quarters · filed 2018-03-01 | $4.74M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $1.42M 10-Q · filed 2017-05-03 | $2.75M derived: sum of 2 quarters · filed 2018-03-01 | $3.36M derived: sum of 3 quarters · filed 2018-03-01 | $3.94M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $1.94M derived: sum of 2 quarters · filed 2018-03-01 | $2.53M derived: sum of 3 quarters · filed 2018-03-01 | $2.90M 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $611.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $1.20M derived: sum of 2 quarters · filed 2016-11-01 | $1.57M 10-Q · filed 2016-11-01 | $1.83M derived: sum of 4 quarters · filed 2017-03-02 | ||||
| 2015-06-30 | $583.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $954.68K 10-Q · filed 2016-08-03 | $1.22M derived: sum of 3 quarters · filed 2017-03-02 | |||||
| 2015-03-31 | $371.17K 10-Q · filed 2016-05-03 | $638.94K derived: sum of 2 quarters · filed 2017-03-02 | ||||||
| 2014-12-31 | $267.77K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $1.30M 10-K · filed 2017-03-02 | ||||||
| 2014-09-30 | $1.03M 10-Q · filed 2015-11-06 | |||||||
| 2013-12-31 | $260.36K 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |